November, 2020
Happy Thanksgiving
Posted on November 26, 2020
Happy Thanksgiving and a big thank you to members of the HD community for your participation in research. Medicine moves…
Read MorePTC Therapeutics Initiates Phase 1 Clinical Trial
Posted on November 19, 2020
PTC Therapeutics is a company focused on developing genetic and small molecule therapies for rare and serious disorders. This week they issued…
Read MoreTriplet Therapeutics SHIELD-HD study fully recruited
Posted on November 12, 2020
Triplet Therapeutics is a Boston-based biotech company that is developing therapies for CAG repeat disorders like HD. Their focus is studying…
Read MoreHDBuzz: Clinical Research Updates from the HSG Conference
Posted on November 5, 2020
The Huntington Study Group hosted a virtual conference from October 29th – 31st, covering clinical trial updates, education, and training for HD…
Read More